Regulatory Open Forum

 View Only
  • 1.  Class II device new license application

    Posted 17-May-2023 16:59

    Hello, 

    I'm preparing a Class II device license application for our device, which has received 510(k) clearance in the US. According to the IMDRF table of contents for Class II devices, only three sections are necessary: (1) Regional Administrative, (2) Submission Context, and (3) Labeling and Promotional Material. In Section 2, Device Description, it is required to provide references and comparisons to similar and/or previous generations of the device. My question is, in Canada, is it true that you only need to provide references and comparisons to similar devices without any additional requirements? Am I missing something? This is my first time handling a submission for Canada, and I feel that its requirements are less stringent. How can this ensure the safety and effectiveness of the device?

    Thank you very much for your help, 

    Linda



    ------------------------------
    Linda Ma
    Cambridge MA
    United States
    ------------------------------


  • 2.  RE: Class II device new license application

    Posted 18-May-2023 08:43

    Hi Linda,

     

    You are correct that the requirements for what is submitted to Health Canada for a Risk Class II medical device is very basic.  This is based on the fact that a risk Class II device is considered a low risk device and that Health Canada accepts the manufacturer's attestation in the application form that they have all the supporting safety and effectiveness data on file to meet the requirements of Sections 10-20 of the Canadian Medical Devices Regulations.  Health Canada always reserves the right to request to see this data on file, but from my experience of submitting licence applications to HC for over 16 years, they have never actually asked for this for a Class II device (other than for high level disinfectants, which is a different story ��).

     

    The Risk Classification of devices in Canada doesn't always line up with how the FDA classifies them, so there are some instances that a device in Canada is considered a Risk Class II, but in the US, it could be a 510(k) or even a PMA if there is no predicate.  There are instances where I have seen the opposite as well of course.

     

    If your IFU/User Manual includes a good description of the device, there is also no need to include the device description in Section 2.  I do typically include a cover letter (though it is not mandatory) to explain any nuances that may cause confusion to the person processing the licence application.

     

    I hope this helps,

     

    Shirley  

     

    Shirley Furesz, Ph.D., RAC

    Amerisource Bergen

    TPIreg, Innomar Strategies

    Director Regulatory Affairs, Medical Devices

     

    Cell phone: 519-242-6476

    Fax: 888-887-8686

     

    3470 Superior Court

    Oakville ON L6L0C4

    Canada

    Regulatory Services | Innomar Strategies (innomar-strategies.com)

     

    United in our responsibility

    to create healthier futures

     






  • 3.  RE: Class II device new license application

    Posted 18-May-2023 10:05

    Hi Shirley, 

    Thank you for your thorough explanation. We have conducted numerous tests to ensure this device is cleared for use in the US. It is pity that they cannot be included in the submission for Canada.

    Thank you again for your response.

    Best regards,

    Linda



    ------------------------------
    Linda Ma
    Cambridge MA
    United States
    ------------------------------



  • 4.  RE: Class II device new license application

    Posted 18-May-2023 15:02

    Hello Linda,

    Indeed it seems counter-intuitive today in the current regulatory world with such demands such as in Europe.  There is indeed only basic information needed in the application which is described in the guidance document and form(s) to use.  You would still want to keep this information because it may be requested, if needed, and would be needed to support any changes.  In Canada, as well as other regulatory regions, confirming safety and efficacy (performance) for a lower risk devices is kept on the responsibility of the manufacturer.  So all of the testing and information is still needed internally, but it must be available if requested.



    ------------------------------
    Richard Vincins ASQ-CQA, MTOPRA, RAC
    Vice President Global Regulatory Affairs
    ------------------------------